Cargando…

Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction

INTRODUCTION: Heart failure is associated with recurrent hospitalizations and high mortality. Guideline directed medical treatment (GDMT), including beta blockers (BBs), angiotensin converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers (ARBs) and aldosterone antagonists (AAs) has show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balakumaran, Kathir, Patil, Aadhar, Marsh, Shannon, Ingrassia, Joseph, Kuo, Chia-Ling, Jacoby, Daniel Louis, Arora, Sabeena, Soucier, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240631/ https://www.ncbi.nlm.nih.gov/pubmed/30480083 http://dx.doi.org/10.1016/j.ijcha.2018.10.003

Ejemplares similares

Impact of Digoxin Use on Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction
por: Jabri, Ahmad, et al.
Publicado: (2022)

Left ventricular apical hypertrophy in a transplanted heart: a case report
por: Ibe, Uzochukwu, et al.
Publicado: (2019)

In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
por: Cox, Zachary L, et al.
Publicado: (2022)

Patient Attributes Associated With Better Long-Term Outcomes on Palliative Milrinone
por: Sharma, Toishi, et al.
Publicado: (2020)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention
por: Romero, Erick, et al.
Publicado: (2023)

Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study
por: Wang, Chen, et al.
Publicado: (2023)

Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction
por: Waranugraha, Yoga, et al.
Publicado: (2021)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Efficacy of guideline‐directed medical treatment in heart failure with mildly reduced ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2022)

Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
por: Bak, Minjung, et al.
Publicado: (2023)

Drug Titration for Patients With Heart Failure With Reduced Ejection Fraction Is a Challenge for Physicians in the Era of Four Pillar Drugs
por: Lee, Sun Hwa
Publicado: (2022)

Titration of medications and outcomes in multi‐ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand
por: Teng, Tiew‐Hwa Katherine, et al.
Publicado: (2023)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Frailty interferes with the guideline‐directed medical therapy in heart failure patients with reduced ejection fraction
por: Hamada, Tomoyuki, et al.
Publicado: (2022)

A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
por: Abdin, Amr, et al.
Publicado: (2022)

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
por: Masarone, Daniele, et al.
Publicado: (2019)

Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry
por: Cowie, Martin R., et al.
Publicado: (2021)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction
por: McCullough, Peter A., et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study
por: Seo, Won-Woo, et al.
Publicado: (2020)

Association between Education Attainment and Guideline-Directed Medication Therapy in Patients with Heart Failure and Reduced Ejection Fraction
por: Long, Juan, et al.
Publicado: (2022)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
por: Dhore-patil, Aneesh, et al.
Publicado: (2022)

Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry
por: de Frutos, Fernando, et al.
Publicado: (2020)

Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fraction
por: Ospina González, Oscar Eduardo, et al.
Publicado: (2023)

Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
por: Parcha, Vibhu, et al.
Publicado: (2021)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction
por: Kondo, Toru, et al.
Publicado: (2023)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study
por: Kocabaş, Umut, et al.
Publicado: (2020)

Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease
por: Chen, Yung-Lung, et al.
Publicado: (2021)

Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction
por: Barry, Arden R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6u6l9nuagku19ss6ve6npe8t2h